Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-06

Clinical Trial Update: Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau Disease

View source ↗

Summary

This clinical trial update describes a completed University Medical Center Groningen study on visualizing VEGF-producing lesions associated with Von Hippel-Lind…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Medical Center Groningen | Conditions: Von Hippel-Lindau Disease, Hemangioblastoma | Status: COMPLETED